PT1733042E - Processo químico-enzimático para preparação de escitalopram - Google Patents

Processo químico-enzimático para preparação de escitalopram Download PDF

Info

Publication number
PT1733042E
PT1733042E PT05718505T PT05718505T PT1733042E PT 1733042 E PT1733042 E PT 1733042E PT 05718505 T PT05718505 T PT 05718505T PT 05718505 T PT05718505 T PT 05718505T PT 1733042 E PT1733042 E PT 1733042E
Authority
PT
Portugal
Prior art keywords
chemo
enzymatic process
escitalopram
preparing
preparing escitalopram
Prior art date
Application number
PT05718505T
Other languages
English (en)
Inventor
Giovanni Cotticelli
Silvia Rocchietti
Marco Terreni
Massimo Pregnolato
Raul Salvetti
Original Assignee
Adorkem Technology Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adorkem Technology Spa filed Critical Adorkem Technology Spa
Publication of PT1733042E publication Critical patent/PT1733042E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
PT05718505T 2004-04-09 2005-04-07 Processo químico-enzimático para preparação de escitalopram PT1733042E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000717A ITMI20040717A1 (it) 2004-04-09 2004-04-09 Procedimento chemo-enzimatico per la preparazione dell'escitalopram

Publications (1)

Publication Number Publication Date
PT1733042E true PT1733042E (pt) 2008-07-29

Family

ID=34967756

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05718505T PT1733042E (pt) 2004-04-09 2005-04-07 Processo químico-enzimático para preparação de escitalopram

Country Status (17)

Country Link
US (1) US7470526B2 (pt)
EP (1) EP1733042B1 (pt)
JP (1) JP2007532106A (pt)
CN (1) CN1946854A (pt)
AT (1) ATE395429T1 (pt)
BR (1) BRPI0508808A (pt)
CA (1) CA2561888A1 (pt)
DE (1) DE602005006770D1 (pt)
DK (1) DK1733042T3 (pt)
ES (1) ES2308465T3 (pt)
HK (1) HK1101827A1 (pt)
IT (1) ITMI20040717A1 (pt)
MX (1) MXPA06011609A (pt)
PL (1) PL1733042T3 (pt)
PT (1) PT1733042E (pt)
SI (1) SI1733042T1 (pt)
WO (1) WO2005098018A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041872A1 (it) 2004-10-01 2005-01-01 Adorkem Technology Spa Processo per la preparazione di citalopram e di scitalopram
EP1736550A1 (en) * 2005-06-22 2006-12-27 Adorkem Technology SpA Chemoenzymatic process for the synthesis of escitalopram
CN106164282A (zh) * 2014-04-10 2016-11-23 Reg生命科学有限责任公司 有机化合物的半合成途径
EP3137614B1 (en) 2014-07-18 2018-09-19 REG Life Sciences, LLC Microbial production of 1,3 diols

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
JPS62151196A (ja) * 1985-09-26 1987-07-06 Nitto Electric Ind Co Ltd l−プロプラノロ−ルの生化学的分離法
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JP3097145B2 (ja) * 1991-02-27 2000-10-10 日産化学工業株式会社 コーリーラクトンジオールの光学分割方法
ES2189502T3 (es) * 1998-10-20 2003-07-01 Lundbeck & Co As H Metodo para la prevencion de citalopram.
EA004742B1 (ru) * 1999-12-28 2004-08-26 Х.Лундбекк А/С Способ получения циталопрама
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram

Also Published As

Publication number Publication date
CA2561888A1 (en) 2005-10-20
MXPA06011609A (es) 2007-01-23
HK1101827A1 (en) 2007-10-26
PL1733042T3 (pl) 2008-10-31
ITMI20040717A1 (it) 2004-07-09
EP1733042B1 (en) 2008-05-14
CN1946854A (zh) 2007-04-11
US20070238887A1 (en) 2007-10-11
US7470526B2 (en) 2008-12-30
ES2308465T3 (es) 2008-12-01
EP1733042A1 (en) 2006-12-20
DE602005006770D1 (de) 2008-06-26
SI1733042T1 (sl) 2008-10-31
JP2007532106A (ja) 2007-11-15
DK1733042T3 (da) 2008-09-08
WO2005098018A1 (en) 2005-10-20
BRPI0508808A (pt) 2007-08-07
ATE395429T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
CA2360287A1 (en) Crystalline base of citalopram
YU49003A (sh) Novi postupak za sintezu fenilamida 5-(4-fluorofenil) -1-(2-((2r,4r)-4-hidroksi-6-okso-tetrahidro-piran-2-il)- etil)-2-izopropil-4-fenil-1h-pirol-3-karboksilne kiseline
HK1101827A1 (en) Chemo-enzymatic process for preparing escitalopram
WO2003043575A3 (en) Process for the synthesis of (r)-1-(3,5-bis(trifluoromethyl)-phenyl)ethan-1-ol and esters thereof by dynamic kinetic resolution
WO2006004977A3 (en) Process for the optical resolution and recycling of tomoxetine
ES2170735A1 (es) Metodo para la preparacion de citalopram.
WO2005068642A3 (en) Bacterial synthesis of 1,2,4-butanetriol enantiomers
EA200200728A1 (ru) Способ получения циталопрама
RS20080401A (en) Method for manufacture of escitalopram
DK1289527T3 (da) (+)-alfa.(2,3-dimethoxyphenyl)-1-(2-(4-fluorphenyl)-ethyl)-4-piperodonmethanol eller dets prolægemiddel til behandling af demens eller kognitiv svækkelse
RS20050105A (en) Process for preparing 5-(4-(54) fluorophenyl)-1-(2-((2r,4r)-4- hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl)- 2-isopropyl-4- phenyl-1h-pyrrole-3- carboxylic acid phenylamide
RS20050760A (sr) Postupak za izradu fenilamida 5-(4- fluorofenil)-1-(2-((2r, 4r)-4-hidroksi- 6-okso-tetrahidro-piran-2-il)etil)-2- izopropil-4-fenil-1h-pirol-3- karboksilne kiseline
BG104073A (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
TW200508392A (en) Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
EP1283200A3 (en) Optically pure paroxetine precursors
WO2001018231A3 (de) VERFAHREN ZUR HERSTELLUNG VON (R)- ODER (S)-HYDROXY-η-BUTYROLACTON
TW200745012A (en) Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds
NO20030876L (no) Fremgangsmåte for racemisering av 1-benzyl-4-(4-fluorfenyl)-3- hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese avparoxetin
ATE344328T1 (de) Verfahren zur herstellung von 1-(3- trifluoromethylphenyl)-propan-2-ol enantiomeren
WO2004076388A3 (en) Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
MX9803646A (es) Un procedimiento para producir derivados de acido 3-fenil-1-metilendioxifenil-indano-2-carboxilico.
WO2006127331A3 (en) Conversion process for 2,3-benzodiazepine enantiomers